Stock 4925 HABA LABORATORIES,INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News HABA Laboratories,Inc.

Equities

4925

JP3765130004

Delayed Japan Exchange
Other stock markets
 01:26:37 2024-05-28 EDT 		5-day change 1st Jan Change
2,095 JPY +0.24% Intraday chart for HABA Laboratories,Inc. +0.58% -3.50%
2023 HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2021 HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index
CI
Tranche Update on HABA Laboratories,Inc.'s Equity Buyback Plan announced on September 6, 2019.
CI
HABA Laboratories,Inc.'s Equity Buyback announced on September 6, 2019 has expired with 152,000 shares for ¥1,133.62 million.
CI
HABA Laboratories,Inc. announces an Equity Buyback for 165,100 shares, representing 4.2% for ¥1,231.32 million.
CI
HABA Laboratories,Inc. authorizes a Buyback Plan.
CI
HABA Laboratories,Inc.(JASDAQ:4925) added to S&P Global BMI Index
CI
Koyanagi Foundation, Endowment Arm acquired 33.9% stake in HABA Laboratories Inc. from Masayuki Koyanagi.
CI
HABA Laboratories Inc. (JASDAQ: 4925) cancelled the acquisition of the remaining 29.07% stake in Chubu HABA Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4925 Stock
  4. News HABA Laboratories,Inc.